Chapter 12
Structuring the Deal
Tax and Accounting Considerations
In matters of style, swim with the current. In matters of principle, stand like a rock.
—Thomas Jefferson
Inside M&A: continued consolidation in the generic pharmaceuticals industry
Teva Pharmaceutical Industries, a manufacturer and distributor of generic drugs, completed its takeover of Ivax Corp for $7.4 billion in early 2006 to become the world's largest manufacturer of generic drugs. For Teva, based in Israel, and Ivax, headquartered in Miami, the merger eliminated a large competitor and created a distribution chain that spans 50 countries.
To broaden the appeal of the proposed merger, Teva offered Ivax shareholders the option to receive for each of their shares either 0.8471 ...
Get Mergers, Acquisitions, and Other Restructuring Activities, 6th Edition now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
